Lilly Knocks On Wood: Transition of Zyprexa Dual Eligibles Moves Along Smoothly
This article was originally published in The Pink Sheet Daily
Executive Summary
Lilly says that it is not hearing any "anecdotal stories" regarding troubles with transitioning dual eligibles taking the atypical antipsychotic to Medicare.